Michael Rawlins - 21 Jun 2021 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
21 Jun 2021
Net transactions value
$0
Form type
4
Filing time
22 Jun 2021, 16:34:11 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 21 Jun 2021 Common Stock 40,000 $43.45 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.